Plano, Texas–(Newsfile Corp. – April 2, 2025) – Okogen Inc., a company specializing in innovative eyecare solutions, today announced the submission of a regulatory application to the Central Drugs Standard Control Organization (CDSCO) in India for its Phase IIb clinical trial, The Emerald Study. In conjunction with this regulatory milestone, …
Read More »
Matribhumi Samachar English